Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy : Pharmacogenetics and Genomics

Secondary Logo

Journal Logo

SHORT COMMUNICATIONS

Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapy

Mirzakhani, Hoomana,b,c,*; van Dormolen, Juliëtd,*; van der Weide, Karene; Guchelaar, Henk-Janc; van Noorden, Martijn S.d; Swen, Jessec

Author Information
Pharmacogenetics and Genomics 25(10):p 515-517, October 2015. | DOI: 10.1097/FPC.0000000000000167

Abstract

Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid